Drug class
Aminosalicylic Acid
Although sometimes used to refer specifically to 4-aminosalicylic acid (an antimycobacterial agent used in tuberculosis) or to the 5-aminosalicylic acid chemical ingredient (mesalamine), the phrase "aminosalicylic acid" generally designates the aminosalicylate therapeutic drug class. Read more about Aminosalicylic Acid
0 drugs in this class 0 manufacturers
Drugs in Aminosalicylic Acid
No drugs are available
This class does not currently contain public drugs.
Although sometimes used to refer specifically to 4-aminosalicylic acid (an antimycobacterial agent used in tuberculosis) or to the 5-aminosalicylic acid chemical ingredient (mesalamine), the phrase "aminosalicylic acid" generally designates the aminosalicylate therapeutic drug class.
These agents are gastrointestinal anti-inflammatory medications that act primarily through local mucosal mechanisms, including inhibition of cyclooxygenase and lipoxygenase pathways, scavenging of free radicals, and activation of peroxisome proliferator-activated receptor-gamma (PPAR-?).
Clinically, drugs within this class—such as mesalamine, sulfasalazine, and balsalazide—serve as standard first-line therapies for the induction and maintenance of remission in mild-to-moderate inflammatory bowel disease, most notably ulcerative colitis.
-
fda.gov
Although sometimes used to refer specifically to 4-aminosalicylic acid (an antimycobacterial agent used in tuberculosis) or to the 5-aminosalicylic acid chemical ingredient (mesalamine), the phrase "aminosalicylic acid" generally designates the aminosalicylate therapeutic drug class
-
nih.gov
Although sometimes used to refer specifically to 4-aminosalicylic acid (an antimycobacterial agent used in tuberculosis) or to the 5-aminosalicylic acid chemical ingredient (mesalamine), the phrase "aminosalicylic acid" generally designates the aminosalicylate therapeutic drug class Clinically, drugs within this class—such as mesalamine, sulfasalazine, and balsalazide—serve as standard first-line therapies for the induction and maintenance of remission in mild-to-moderate inflammatory bowel dise...
-
rxlist.com
Although sometimes used to refer specifically to 4-aminosalicylic acid (an antimycobacterial agent used in tuberculosis) or to the 5-aminosalicylic acid chemical ingredient (mesalamine), the phrase "aminosalicylic acid" generally designates the aminosalicylate therapeutic drug class
-
nih.gov
These agents are gastrointestinal anti-inflammatory medications that act primarily through local mucosal mechanisms, including inhibition of cyclooxygenase and lipoxygenase pathways, scavenging of free radicals, and activation of peroxisome proliferator-activated receptor-gamma (PPAR-γ)
-
nih.gov
These agents are gastrointestinal anti-inflammatory medications that act primarily through local mucosal mechanisms, including inhibition of cyclooxygenase and lipoxygenase pathways, scavenging of free radicals, and activation of peroxisome proliferator-activated receptor-gamma (PPAR-γ)
-
nih.gov
These agents are gastrointestinal anti-inflammatory medications that act primarily through local mucosal mechanisms, including inhibition of cyclooxygenase and lipoxygenase pathways, scavenging of free radicals, and activation of peroxisome proliferator-activated receptor-gamma (PPAR-γ)
-
fda.gov
Clinically, drugs within this class—such as mesalamine, sulfasalazine, and balsalazide—serve as standard first-line therapies for the induction and maintenance of remission in mild-to-moderate inflammatory bowel disease, most notably ulcerative colitis
-
fda.gov
Clinically, drugs within this class—such as mesalamine, sulfasalazine, and balsalazide—serve as standard first-line therapies for the induction and maintenance of remission in mild-to-moderate inflammatory bowel disease, most notably ulcerative colitis
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.